SUNITINIB

Description

Sunitinib – Targeted Therapy for Advanced Cancers

Overview

Sunitinib is a prescription oral medication classified as a multi-kinase inhibitor. It works by blocking enzymes that promote tumor growth and the formation of new blood vessels, making it an effective targeted therapy for certain advanced cancers. Sunitinib is commonly used in the treatment of advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST) after prior therapy, and pancreatic neuroendocrine tumors (pNET), helping to slow disease progression and improve patient outcomes.

Key Features / Indications

• Active Ingredient: Sunitinib
• Therapeutic Class: Multi-Kinase Inhibitor / Targeted Therapy
• Indications:

o Advanced renal cell carcinoma (RCC)

o Gastrointestinal stromal tumors (GIST) after prior treatment

o Pancreatic neuroendocrine tumors (pNET)

• Administration: Oral capsules, taken once daily as prescribed
• Mechanism of Action: Inhibits multiple tyrosine kinases involved in tumor growth and angiogenesis, reducing tumor proliferation and metastasis
• Benefits:

o Targeted therapy for multiple advanced cancers

o Oral administration for patient convenience

o Slows tumor progression and improves survival in previously treated patients

Why Choose Oncomed Pharmacy?

Oncomed Pharmacy provides authentic, high-quality Sunitinib with safe storage, handling, and professional guidance. Our pharmacists assist with proper dosing, side-effect management, and ongoing patient support, ensuring therapy is safe and effective. Choosing Oncomed Pharmacy guarantees access to essential oncology medications with dedicated care throughout your treatment journey.

Uses of Medicine

Sunitinib is primarily used for:

• Treating advanced renal cell carcinoma (RCC)
• Managing gastrointestinal stromal tumors (GIST) after prior therapy
• Treating pancreatic neuroendocrine tumors (pNET)
• Slowing tumor growth and disease progression in advanced cancers
• Supporting targeted therapy regimens for improved patient outcomes